High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome.

@article{Richardson2006HighCR,
  title={High clinical response rate with multimodality immunomodulatory therapy for S{\'e}zary syndrome.},
  author={Stephen K. Richardson and Julie H. Lin and Carmela C. Vittorio and Ellen J. Kim and Jessica S Yoon and Jacqueline M. Junkins-Hopkins and Alain H. Rook},
  journal={Clinical lymphoma & myeloma},
  year={2006},
  volume={7 3},
  pages={226-32}
}
PURPOSE The goal of this study was to evaluate the clinical response rate of patients with Sézary syndrome (SS) to multimodality immunomodulatory therapy consisting of extracorporeal photopheresis in combination with >/= 2 systemic biologic response modifiers (interferon-, interferon-, retinoids, and/or sargramostim) and psoralen plus UV-A. PATIENTS AND METHODS Twenty-eight patients who met established criteria for SS were treated with multimodality immunomodulatory therapy at the Hospital of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…